REFERENCES


Gene Name Pubmed ID Classification Sample Location Remark
SFRP1 16434596MethylationDakar, SenegalThis gene has been found to be hypermethylated in in a high proportion of invasive cervical cancer clinical samples (86.4%) and therefore has been suggested as a therapeutic target  
SFRP1 19513747MethylationTri-Service General Hospital, Taipei, Taiwan.The frequency of this gene promoter hypermethylation In adenocarcinoma of cervix samples is 52.2% (p<0.001).  
SFRP1 19038436MethylationTri-Service General Hospital, Taipei, Taiwan.This gene is hypermethylated in 33.9% of SCC, 8.2% of HSIL, 2.2% of LSIL but not in normal tissues.